Fischer Medical Ventures Ltd.
NSE: FISCHER BSE: FISCHER
Prev Close
40.04
Open Price
40.31
Volume
1,346,791
Today Low / High
38.51 / 40.84
52 WK Low / High
33.94 / 124.7
Range
37 - 41
Prev Close
40.25
Open Price
41
Volume
186,002
Today Low / High
38.55 / 41
52 WK Low / High
33.1 / 124.2
Range
37 - 41
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 38.76 (target range: 37 - 41), reflecting a change of -1.28 (-3.1968%). On the BSE, it is listed at 38.72 (target range: 37 - 41), showing a change of -1.53 (-3.80124%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Fischer Medical Ventures Ltd. Graph
Fischer Medical Ventures Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Fischer Medical Ventures Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 38.76, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 38.72 | 39.11 | 35.20 - 43.02 |
| 39.49 | 31.60 - 47.39 | ||
| 39.88 | 27.92 - 51.85 | ||
| Bearish Scenario | 38.72 | 38.33 | 34.50 - 42.17 |
| 37.95 | 30.36 - 45.53 | ||
| 37.56 | 26.29 - 48.83 |
Overview of Fischer Medical Ventures Ltd.
ISIN
INE771F01041
Industry
Medical - Devices
Vol.Avg
1,785,564
Market Cap
25,292,103,330
Last Dividend
0.005
Official Website
IPO Date
2025-07-10
DCF Diff
67.81
DCF
-32
Financial Ratios Every Investor Needs
Stock Dividend of FISCHER
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-22 | September 22, 25 | 0.005 | 0.005 | 2025-09-22 | 2025-10-29 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 110.70 Cr | 91.59 Cr | 19.11 Cr | 0.1726 | 0.00 Cr | 4.18 Cr | 3.06 Cr | 1.21 Cr | 0.01 | 4.26 Cr | 0.0109 |
| 2024-03-31 | 20.98 Cr | 16.45 Cr | 4.53 Cr | 0.2158 | 0.00 Cr | 0.52 Cr | 1.68 Cr | 1.84 Cr | 0.17 | 2.36 Cr | 0.0876 |
| 2023-03-31 | 0.18 Cr | 0.00 Cr | 0.18 Cr | 1.0000 | 0.00 Cr | 0.04 Cr | 0.02 Cr | -0.04 Cr | -0.21 | 0.02 Cr | -0.2033 |
| 2022-03-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | 0.00 Cr | 0.02 Cr | 0.00 Cr | -0.23 Cr | -1.35 | -0.19 Cr | 0.0000 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 104.26 Cr | 457.37 Cr | 119.50 Cr | 337.5239 Cr | 85.37 Cr | -18.89 Cr | 9.16 Cr | 40.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 101.8210 Cr |
| 2024-03-31 | 0.95 Cr | 86.32 Cr | 5.21 Cr | 81.1145 Cr | 1.68 Cr | 0.73 Cr | 4.48 Cr | 12.49 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 3.8322 Cr |
| 2023-03-31 | 0.04 Cr | 0.35 Cr | 0.62 Cr | -0.2660 Cr | 1.14 Cr | 1.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0478 Cr |
| 2022-03-31 | 0.02 Cr | 0.19 Cr | 0.42 Cr | -0.2295 Cr | 0.39 Cr | 0.37 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.4198 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -86.7383 Cr | -124.8766 Cr | 314.9244 Cr | -92.7255 Cr | 103.3145 Cr | 104.2628 Cr | -5.9872 Cr | 2.2227 Cr | 59.8792 Cr | 0.0000 Cr | -3.4068 Cr |
| 2024-03-31 | -7.3520 Cr | -31.3857 Cr | 37.0572 Cr | -7.8369 Cr | 0.9125 Cr | 0.9483 Cr | -0.4849 Cr | 2.1112 Cr | -0.5717 Cr | 0.0000 Cr | 17.5211 Cr |
| 2023-03-31 | -0.1459 Cr | 0.0000 Cr | 0.1660 Cr | -0.1459 Cr | 0.0202 Cr | 0.0358 Cr | 0.0000 Cr | -0.0013 Cr | 0.1677 Cr | 0.0000 Cr | 0.0000 Cr |
| 2022-03-31 | -0.1769 Cr | 0.0000 Cr | 0.1476 Cr | -0.1769 Cr | -0.0293 Cr | 0.0156 Cr | 0.0000 Cr | -0.1974 Cr | 0.1485 Cr | 0.0000 Cr | 0.0000 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 101.10 Cr | 55.10 Cr | 45.99 Cr | 0.4549 | 20.79 Cr | 19.23 Cr | 0.30 | 21.57 Cr | 0.1903 |
| 2025-09-30 | 86.31 Cr | 65.90 Cr | 20.41 Cr | 0.2365 | 15.74 Cr | 13.90 Cr | 0.21 | 18.74 Cr | 0.1610 |
| 2025-06-30 | 23.44 Cr | 12.76 Cr | 10.68 Cr | 0.4556 | 3.49 Cr | 5.01 Cr | 0.01 | 11.61 Cr | 0.2136 |
| 2025-03-31 | 49.17 Cr | 39.31 Cr | 9.86 Cr | 0.2006 | 3.37 Cr | 1.31 Cr | 0.00 | 2.48 Cr | 0.0267 |
| 2024-12-31 | 11.75 Cr | 7.54 Cr | 4.21 Cr | 0.3583 | -0.06 Cr | -0.29 Cr | -0.01 | 0.75 Cr | -0.0250 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 42.87 Cr | 0.00 Cr | 42.87 Cr | 162.27 Cr | 5.25 Cr | 262.96 Cr | 28.03 Cr | 467.65 Cr | 107.10 Cr |
| 2025-03-31 | 104.26 Cr | 147.09 Cr | 251.36 Cr | 76.18 Cr | 9.16 Cr | 365.29 Cr | 40.01 Cr | 457.37 Cr | 119.50 Cr |
| 2024-09-30 | 1.90 Cr | 11.75 Cr | 13.66 Cr | 75.82 Cr | 18.12 Cr | 111.02 Cr | 13.97 Cr | 140.72 Cr | 58.04 Cr |
| 2024-03-31 | 0.95 Cr | 37.00 Cr | 37.95 Cr | 23.26 Cr | 4.48 Cr | 70.41 Cr | 12.49 Cr | 86.32 Cr | 5.21 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial cash flow statement data available. | |||||||||
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Devices
No stocks found in this industry.
Key Executives
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1950
Gender: male
Year Born: 1974
Gender: male
Year Born:
Gender: female
Year Born:
FAQs about Fischer Medical Ventures Ltd.
The CEO is Ravindran Govindan.
The current price is ₹39.00.
The range is ₹33.94-124.7.
The market capitalization is ₹2,529.21 crores.
The dividend yield is 0.01%.
The P/E ratio is 64.11.
The company operates in the Healthcare sector.
Overview of Fischer Medical Ventures Ltd. (ISIN: INE771F01041) is a leading Medical - Devices in India. With a market capitalization of ₹2,529.21 crores and an average daily volume of 1,785,564 shares, it operates in the Medical - Devices. The company last declared a dividend of ₹0.005.